Furthermore, curcumin, losartan, and anti-LOX-1 antibodies were found to attenuate Ang II-mediated oxidative stress, the expression of NOX and NF-κB as well as cardiac hypertrophy [157]. This evidence concerns the gene NFKB1 and cardiac hypertrophy.